See the notice on TED website
1. Buyer
1.1.
Buyer
Official name: Cliniques universitaires Saint Luc
Legal type of the buyer: Central government authority
Activity of the contracting authority: Health
1.1.
Buyer
Official name: Clinique Saint-Jean
Legal type of the buyer: Central government authority
Activity of the contracting authority: Health
2. Procedure
2.1.
Procedure
Title: Médicaments pour la procréation médicalement assistée
Description: Le marché public a pour objet les fournitures de médicaments pour la procréation médicalement assistée. Le marché est divisé en lots comme suit : - Lot 1 « Antagoniste injectable » ; - Lot 2 « Agoniste GnRH injectable pour injections quotidiennes » ; - Lot 3 « FSH recombinante à courte durée d’action » ; - Lot 4 « FSH recombinante à courte durée d’action avec algorithme » ; - Lot 5 « Gonadotrophines urinaires : rapport LH-FSH identique + hCG » ; - Lot 6 « Gonadotrophines chorioniques » ; - Lot 7 « Gonadotrophines recombinantes longue action ».
Procedure identifier: bcc61b22-a9f3-4976-b980-a5c093ce9d89
Internal identifier: PHARM-2026-840
Type of procedure: Open
The procedure is accelerated: no
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
2.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
2.1.4.
General information
Legal basis:
Directive 2014/24/EU
2.1.5.
Terms of procurement
Terms of submission:
Maximum number of lots for which one tenderer can submit tenders: 7
Terms of contract:
Maximum number of lots for which contracts can be awarded to one tenderer: 7
2.1.6.
Grounds for exclusion
Sources of grounds for exclusion: European Single Procurement Document (ESPD)
5. Lot
5.1.
Lot: LOT-0001
Title: PHARM-2026-840 - 1
Description: Fournitures d'antagoniste injectable.
Internal identifier: 1
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0002
Title: PHARM-2026-840 - 2
Description: Fournitures d'agoniste GnRH injectable pour injections quotidiennes.
Internal identifier: 2
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0003
Title: PHARM-2026-840 - 3
Description: Fournitures de FSH recombinante à courte durée d’action.
Internal identifier: 3
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 2
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0004
Title: PHARM-2026-840 - 4
Description: Fournitures de FSH recombinante à courte durée d’action avec algorithme.
Internal identifier: 4
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0005
Title: PHARM-2026-840 - 5
Description: Fournitures de gonadotrophines urinaires : rapport LH-FSH identique + hCG.
Internal identifier: 5
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0006
Title: PHARM-2026-840 - 6
Description: Fournitures de gonadotrophines chorioniques.
Internal identifier: 6
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
5.1.
Lot: LOT-0007
Title: PHARM-2026-840 - 7
Description: Fournitures de gonadotrophines recombinantes longue action.
Internal identifier: 7
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33641000 Medicinal products for the genitourinary system and sex hormones
5.1.2.
Place of performance
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
5.1.3.
Estimated duration
Duration: 4 Years
5.1.6.
General information
Reserved participation:
Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.9.
Selection criteria
Sources of selection criteria: Procurement Document
5.1.11.
Procurement documents
Ad hoc communication channel:
5.1.12.
Terms of procurement
Terms of submission:
Electronic submission: Required
Languages in which tenders or requests to participate may be submitted: French
Electronic catalogue: Not allowed
Advanced or qualified electronic signature or seal (as defined in Regulation (EU) No 910/2014) is required
Deadline for receipt of tenders: 09/06/2026 09:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Duration during which the tender must remain valid: 180 Days
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.15.
Techniques
Framework agreement:
Framework agreement, without reopening of competition
Maximum number of participants: 1
Information about the dynamic purchasing system:
No dynamic purchase system
5.1.16.
Further information, mediation and review
Review organisation: Tribunal de première instance francophone de Bruxelles
Information about review deadlines: cf: documents du marché
8. Organisations
8.1.
ORG-0001
Official name: Cliniques universitaires Saint Luc
Registration number: 0416885016_5176
Department: Département Pharmacie
Postal address: Avenue Hippocrate, 10
Town: Woluwe-Saint-Lambert
Postcode: 1200
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
Telephone: +32 27643692
Roles of this organisation:
Buyer
8.1.
ORG-0002
Official name: SPF Stratégie et Appui
Registration number: BE001
Postal address: Boulevard Simon Bolivar 30 Bte1
Town: Bruxelles
Postcode: 1000
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
Telephone: +32 2 740 80 00
Roles of this organisation:
TED eSender
8.1.
ORG-0003
Official name: Clinique Saint-Jean
Registration number: 0813109725
Town: Bruxelles
Postcode: 1000
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
Telephone: +3228910804
Roles of this organisation:
Buyer
8.1.
ORG-0004
Official name: Tribunal de première instance francophone de Bruxelles
Registration number: B20308357753
Town: Bruxelles
Postcode: 1000
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
Country: Belgium
Roles of this organisation:
Review organisation
10. Change
Version of the previous notice to be changed: 51b2d2f0-3e39-4d5a-9a58-54d6bed8c498-01
Main reason for change: Information updated
Description: La date limite de soumission est reportée. Elle est désormais fixée au 9 juin 2026. Cette date remplace toute communication antérieure relative à la date limite de remise des offres.
Notice information
Notice identifier/version: 49d08f32-4045-4df6-a8fb-df2e97207721 - 01
Form type: Competition
Notice type: Contract or concession notice – standard regime
Notice subtype: 16
Notice dispatch date: 30/04/2026 00:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Notice dispatch date (eSender): 30/04/2026 00:00:00 (UTC+02:00) Eastern European Time, Central European Summer Time
Languages in which this notice is officially available: French
Notice publication number: 301359-2026
OJ S issue number: 85/2026
Publication date: 04/05/2026